B-cell lymphoma

IRVINE, California, May 29, 2026 PeproMene Bio, Inc. has announced that updated clinical data from its ongoing Phase 1...

WELLINGTON, New Zealand – May 6, 2026 BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) have signed a binding...

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has...